Drugmakers sign letter supporting FDA and calling for reversal of Texas judge’s mifepristone drug ruling

Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome

Sanofi’s Tzield gains approval in China for T1D management

Capricor refutes FDA’s DMD deramiocel rejection in public statement

Health Canada approves Medison and Ipsen’s Bylvay to treat ALGS